Democrat's vice-presidential candidate Kamala Harris on Saturday said that if a vaccine for COVID-19 is available before November's election, she would not take President Trump's word on its safety and efficacy.

'Will not trust him': Kamala Harris on Donald Trump's pre-election vaccine

India has again reiterated that when it comes to COVID-19 vaccine, Bangladesh will get a priority. Ministry of external affairs spokesperson Anurag Shrivastava in his weekly presser said, "As a close neighbour and strategic partner, we have assured the Bangladesh side that Bangladesh will get high priority in supply of vaccine, once ready.

Bangladesh a priority for Indian COVID-19 vaccine: India

The Chinese government has been administering a coronavirus vaccine candidate to selected groups of key workers since July. According to Zheng Zhongwai, the head of National Health Commission potential vaccines has been given to workers in high-risk jobs.

Coronavirus Pandemic: China approved emergency use of potential vaccine since July

The Drug Regulatory Authority of Pakistan (DRAP) has given a nod for phase-III clinical trial of a COVID-19 vaccine developed in collaboration with a Chinese company, a media report said on Tuesday.

Pakistan to conduct phase-III clinical trial of coronavirus vaccine

French healthcare company Sanofi SA has agreed to buy U.S. company Principia Biopharma Inc for around $3.7 billion, the companies said on Monday, strengthening Sanofi`s presence in research and development (R&D) areas.

French group Sanofi to buy US firm Principia Biopharma for $3.7 billion

China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country`s intellectual property regulator.

China grants country's first COVID-19 vaccine patent to CanSino

Russia said Saturday that it has produced the first batch of its coronavirus vaccine, after President Vladimir Putin announced it had been first in the world to approve a vaccine.

Russia begins production of the first batch of coronavirus vaccine

Russian President Vladamir Putin proudly announced the approval of the world's first COVID-19 vaccine. A Russian doctor has raised some concerns over the use of vaccines. Watch report.

COVID-19 Pandemic: Russian doctor flags concerns regarding use of Sputnik V

The race to find an effective coronavirus vaccine has global implications, not just for the health of billions of people, but potential billions in revenue for the successful developer and manufacturer.

Russia offers to help US with COVID-19 vaccine. 'No way in hell,' says America

The World Health Organization says the vaccine approved by Russia this week is not among the nine that it considers in the advanced stages of testing. WHO and partners have included nine experimental COVID-19 vaccines within an investment mechanism it is encouraging countries to join, known as the Covax facility.

Russia's first Covid-19 vaccine not in advanced test stages: WHO

Vaccine producers in China have warned the country's citizens not to to fall for fake advertisements online about coronavirus vaccine. The warning came after a fake ad of a vaccine allegedly produced by Sinovac Biotech circulated on social media platform WeChat and only accepting advanced payment.

Chinese warned to stay away from COVID-19 vaccine scams on social media

The Philippines plans to launch clinical trials for a Russian coronavirus vaccine in October, with President Rodrigo Duterte expected to be inoculated as early as May next year, the presidential spokesman said on Thursday.

Phase 3 trials of Russian COVID-19 vaccine to start in Philippines in October

There are several contenders global as well as domestic in the race to develop the COVID-19 vaccine. Watch report.

Who all are the major COVID-19 vaccine global and domestic contenders | World News

Russia's health minister is preparing a mass vaccination campaign against the novel coronavirus for October, local news agencies reported on Saturday, after a vaccine completed clinical trials.

Russia preparing mass vaccination against COVID-19 for October

Top US infectious disease expert Dr. Anthony Fauci on Friday has raised concerns over the safety of COVID-19 vaccines being developed by China and Russia as the world scrambles for answers to a pandemic the WHO warned will be felt for decades.

US says unlikely to use China, Russia COVID-19 vaccine as race heats up

China has rejected charges that hackers linked to its government targetted biotech firm Moderna Inc, a leading US-based coronavirus vaccine research developer, to steal data.

China dismisses accusations of hacking attempt on US vaccine developer Moderna

Russia is preparing to be the first in the world to approve a coronavirus vaccine, in less than two weeks -- despite concerns about its effectiveness. According to CNN, Russian officials are working toward a date of August 10 or earlier for approval of the vaccine, which has been created by the Moscow-based Gamaleya Institute.

Russia intends to be world's first approval of COVID-19 vaccine by mid-August

Is the developed world locking up Wuhan Virus vaccine supplies - even before the scientists come up with one? WION's Palki Sharma tells you how leading countries have already ordered millions of doses in advance.

Gravitas: Vaccine for Wuhan Virus, Will the developed world lock up supplies?

Russia said Wednesday that it plans to begin production of two "promising" coronavirus vaccines in September and October as Moscow races to develop a formula before Western countries.

Russia vows 'promising' coronavirus vaccines in September

Pharma giants Sanofi and GSK said Wednesday they have agreed to supply Britain with up to 60 million doses of a potential COVID-19 vaccine. The agreement covers a vaccine candidate developed by France's Sanofi in partnership with the UK's GSK and is subject to a "final contract".

UK signs up for Sanofi-GSK coronavirus vaccine

The U.S. government will pay nearly $2 billion to buy enough of a COVID-19 vaccine being developed by Pfizer Inc and German biotech BioNTech SE to innoculate 50 million people if it proves to be safe and effective, the companies said on Wednesday.

US to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine

A coronavirus vaccine candidate developed by China National Pharmaceutical Group (Sinopharm) could be ready for public use by the end of this year, state media reported on Wednesday.

China's Sinopharm says coronavirus vaccine could be ready by year-end

The first shipment of a potential COVID-19 vaccine being developed by China has now landed in Brazil. Sao Paulo has received 20,000 doses of CoronaVac which is being developed with a Chinese frim Sinovac. Watch report.

Why is China conducting Phase-3 trials in other countries: China's vaccine test to start in Brazil

India's first coronavirus vaccine 'COVAXIN' human trials will begin on July 21 at the All India Institute of Medical Science (AIIMS), Delhi after its Ethics Committee gave its nod. COVAXIN is an indigenously developed COVID-19 vaccine. Watch report.

'Covaxin' human trial begins in AIIMS: Phase 1 & 2 trials of potential vaccine

covid-19-vaccine

Covid 19 Vaccine, News on Covid 19 Vaccine, stories on Covid 19 Vaccine, articles on Covid 19 Vaccine, Covid 19 Vaccine stories at Wion, Covid 19 Vaccine news, Covid 19 Vaccine latest news

covid 19-vaccine